{"title":"Watch and wait in early onset rectal cancer patients: A review of the literature","authors":"Melissa K Drezdzon , Carrie Y Peterson","doi":"10.1016/j.scrs.2025.101117","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Despite the general decline in rectal cancer<span> diagnoses, early onset rectal cancer (EORC) diagnoses are increasing. Meanwhile, Watch and Wait (WW) surveillance for patients with complete clinical response to neoadjuvant therapy is gaining popularity. While outcomes for WW are good, there may be hesitancy enrolling younger patients. This review aimed to evaluate literature examining WW in EORC patients.</span></div></div><div><h3>Methods</h3><div><span>A systematic literature review was conducted and full-text, peer-reviewed manuscripts were assessed for eligibility. A single study, “</span><em>Watch and Wait After a Clinical Complete Response in Rectal Cancer Patients Younger than 50 Years,”</em> by Bahadoer et al. (2021) was identified.</div></div><div><h3>Results</h3><div>The study included 199 EORC patients followed for a mean of 3.2 years. Compared to older patients, EORC patients had higher overall survival, and similar rates of disease-free survival and local recurrence.</div></div><div><h3>Discussion</h3><div>The results of the identified study are encouraging, however, there is a paucity of data on WW in EORC patients, including not only clinical outcomes but surveillance compliance and barriers that might inform treatment decision-making. Decisions regarding WW in EORC patients should be made on an individual case after thorough discussion with patients.</div></div>","PeriodicalId":55956,"journal":{"name":"Seminars in Colon and Rectal Surgery","volume":"36 3","pages":"Article 101117"},"PeriodicalIF":0.5000,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in Colon and Rectal Surgery","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1043148925000387","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Despite the general decline in rectal cancer diagnoses, early onset rectal cancer (EORC) diagnoses are increasing. Meanwhile, Watch and Wait (WW) surveillance for patients with complete clinical response to neoadjuvant therapy is gaining popularity. While outcomes for WW are good, there may be hesitancy enrolling younger patients. This review aimed to evaluate literature examining WW in EORC patients.
Methods
A systematic literature review was conducted and full-text, peer-reviewed manuscripts were assessed for eligibility. A single study, “Watch and Wait After a Clinical Complete Response in Rectal Cancer Patients Younger than 50 Years,” by Bahadoer et al. (2021) was identified.
Results
The study included 199 EORC patients followed for a mean of 3.2 years. Compared to older patients, EORC patients had higher overall survival, and similar rates of disease-free survival and local recurrence.
Discussion
The results of the identified study are encouraging, however, there is a paucity of data on WW in EORC patients, including not only clinical outcomes but surveillance compliance and barriers that might inform treatment decision-making. Decisions regarding WW in EORC patients should be made on an individual case after thorough discussion with patients.
期刊介绍:
Seminars in Colon and Rectal Surgery offers a comprehensive and coordinated review of a single, timely topic related to the diagnosis and treatment of proctologic diseases. Each issue is an organized compendium of practical information that serves as a lasting reference for colorectal surgeons, general surgeons, surgeons in training and their colleagues in medicine with an interest in colorectal disorders.